hydroxyproline has been researched along with Disease Exacerbation in 39 studies
Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " LVH was characterized by increases in the ratios of heart and left ventricular weights to body weight, increased myocyte cross-sectional areas, myocardial and perivascular fibrosis, and elevated cardiac hydroxyproline." | 3.75 | K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function. ( Gao, S; Long, CL; Wang, H; Wang, RH, 2009) |
| "The mutant MCP-1 treated group inhibited early pancreatic inflammation and later pancreatic fibrosis histologically, and showed a decrease in serum MCP-1 concentration, intrapancreatic hydroxyproline, alpha-smooth muscle actin, and an increase in intrapancreatic amylase and protein content compared with the empty plasmid treated group." | 3.73 | Anti-monocyte chemoattractant protein 1 gene therapy attenuates experimental chronic pancreatitis induced by dibutyltin dichloride in rats. ( Arita, Y; Egashira, K; Gibo, J; Ito, T; Kaku, T; Kawabe, K; Nawata, H; Oono, T; Usui, M; Zhao, HF; Zhao, QW, 2005) |
| "Early detection and accurate staging of liver fibrosis is critically important for patient management." | 1.51 | Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH). ( Boominathan, R; Cheng, P; Chong, YC; Deng, X; Goggi, JL; Han, W; Hartimath, SV; Robins, EG; Soh, V; Tan, PW; Yong, FF, 2019) |
| "To understand the mechanisms underlying pulmonary fibrosis and assess potential therapies, mouse models are central to basic and translational research." | 1.46 | Magnetic resonance imaging of disease progression and resolution in a transgenic mouse model of pulmonary fibrosis. ( Akinyi, TG; Cleveland, ZI; Davidson, CR; Dunn, RS; Guo, J; Hardie, WD; Woods, JC; Zhou, YM, 2017) |
| "Pulmonary fibrosis is caused by excessive proliferation and accumulation of stromal cells." | 1.40 | Bone marrow-derived stromal cells are invasive and hyperproliferative and alter transforming growth factor-α-induced pulmonary fibrosis. ( Davidson, C; Edukulla, R; Hardie, WD; Ikegami, M; Madala, SK; Schmidt, S, 2014) |
| "However, the effects of WHP on liver fibrosis remain unknown." | 1.40 | Whey-hydrolyzed peptide-enriched immunomodulating diet prevents progression of liver cirrhosis in rats. ( Endo, K; Hori, T; Iwaisako, K; Jobara, K; Kaido, T; Uchida, Y; Uemoto, S, 2014) |
| "Idiopathic pulmonary fibrosis (IPF) is thought to involve inflammatory cells and reactive oxygen species (ROS), such as superoxide anion radical (O2(·-))." | 1.39 | Long-acting human serum albumin-thioredoxin fusion protein suppresses bleomycin-induced pulmonary fibrosis progression. ( Chuang, VT; Hamasaki, K; Ishima, Y; Kodama, A; Maruyama, T; Mizushima, T; Otagiri, M; Tanaka, K; Tanaka, R; Watanabe, H, 2013) |
| "Pranlukast attenuates the progression of pulmonary fibrosis in the chronic phase but has no effect on the acute inflammatory response or on the onset of pulmonary fibrosis." | 1.38 | Pranlukast, a cysteinyl leukotriene type 1 receptor antagonist, attenuates the progression but not the onset of silica-induced pulmonary fibrosis in mice. ( Okunishi, H; Shimbori, C; Shiota, N, 2012) |
| "Hydroxyproline was found in all pepsin-solutions but in no trypsin- or HCl-solutions." | 1.36 | Influence of the digestive enzymes trypsin and pepsin in vitro on the progression of erosion in dentine. ( Ganss, C; Hardt, M; Klimek, J; Schlueter, N, 2010) |
| "Idiopathic pulmonary fibrosis (IPF) is a treatment resistant disease with poor prognosis." | 1.35 | Comparison between conventional and "clinical" assessment of experimental lung fibrosis. ( Ask, K; Farkas, L; Farncombe, T; Froese, A; Gauldie, J; Inman, M; Kolb, MR; Labiris, R; McClelland, GB; Moeller, A, 2008) |
| "Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fibrotic lung disorder of unknown cause." | 1.34 | Control of virus reactivation arrests pulmonary herpesvirus-induced fibrosis in IFN-gamma receptor-deficient mice. ( Brigham, K; Mora, AL; Ritzenthaler, J; Rojas, M; Roman, J; Speck, SH; Stecenko, A; Torres-González, E; Xu, J, 2007) |
| " Although a daily dosage of isoflavone was not sufficient to prevent tissue fibrosis under marked oxidative stress in the early stage of diabetes, isoflavones might promise significant clinical benefits by reducing oxidative stress in the heart during aging." | 1.34 | Inhibitory effects of soy isoflavones on cardiovascular collagen accumulation in rats. ( Ebihara, K; Kishida, T; Miyatake, A; Mizushige, K; Mizushige, T, 2007) |
| "Fibrosis is a hallmark of progressive organ disease." | 1.34 | Blockade of IP-10/CXCR3 promotes progressive renal fibrosis. ( Furuichi, K; Gerard, C; Haino, M; Ishida, Y; Kaneko, S; Kawachi, H; Kitagawa, K; Kondo, T; Matsushima, K; Nakaya, I; Narumi, S; Sakai, N; Shimizu, F; Sugaya, T; Wada, T; Yokoyama, H, 2007) |
| "Cystamine can ameliorate CCl(4) induced liver fibrosis and protect hepatic function." | 1.34 | Cystamine ameliorates liver fibrosis induced by carbon tetrachloride via inhibition of tissue transglutaminase. ( Chen, W; Qiu, JF; Wu, ZY; Zhang, ZQ, 2007) |
| "The hydroxyproline content was significantly higher in the control groups than in the DMN+LSKL group." | 1.32 | A blocking peptide for transforming growth factor-beta1 activation prevents hepatic fibrosis in vivo. ( Etani, Y; Kondou, H; Michigami, T; Miyoshi, Y; Mushiake, S; Ozono, K, 2003) |
| "Spinal deformity in the form of kyphosis or kyphoscoliosis occurs in most patients with Duchenne muscular dystrophy (DMD), a fatal X-linked disorder caused by an absence of the subsarcolemmal protein dystrophin." | 1.32 | Progression of kyphosis in mdx mice. ( Hoey, A; Laws, N, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.56) | 18.2507 |
| 2000's | 20 (51.28) | 29.6817 |
| 2010's | 18 (46.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hartimath, SV | 1 |
| Boominathan, R | 1 |
| Soh, V | 1 |
| Cheng, P | 1 |
| Deng, X | 1 |
| Chong, YC | 1 |
| Yong, FF | 1 |
| Tan, PW | 1 |
| Han, W | 1 |
| Robins, EG | 1 |
| Goggi, JL | 1 |
| Kim, LB | 2 |
| Shkurupy, VA | 1 |
| Putyatina, AN | 1 |
| Gaugg, MT | 1 |
| Engler, A | 1 |
| Bregy, L | 1 |
| Nussbaumer-Ochsner, Y | 1 |
| Eiffert, L | 1 |
| Bruderer, T | 1 |
| Zenobi, R | 1 |
| Sinues, P | 1 |
| Kohler, M | 1 |
| Tanaka, R | 1 |
| Watanabe, H | 1 |
| Kodama, A | 1 |
| Chuang, VT | 1 |
| Ishima, Y | 1 |
| Hamasaki, K | 1 |
| Tanaka, K | 1 |
| Mizushima, T | 1 |
| Otagiri, M | 1 |
| Maruyama, T | 1 |
| Madala, SK | 1 |
| Edukulla, R | 1 |
| Schmidt, S | 1 |
| Davidson, C | 1 |
| Ikegami, M | 1 |
| Hardie, WD | 2 |
| Said, E | 1 |
| Said, SA | 1 |
| Gameil, NM | 1 |
| Ammar, EM | 1 |
| Jobara, K | 1 |
| Kaido, T | 1 |
| Hori, T | 1 |
| Iwaisako, K | 1 |
| Endo, K | 1 |
| Uchida, Y | 1 |
| Uemoto, S | 1 |
| Lucattelli, M | 1 |
| Fineschi, S | 1 |
| Selvi, E | 1 |
| Garcia Gonzalez, E | 1 |
| Bartalesi, B | 1 |
| De Cunto, G | 1 |
| Lorenzini, S | 1 |
| Galeazzi, M | 1 |
| Lungarella, G | 1 |
| Kim, YO | 1 |
| Popov, Y | 1 |
| Schuppan, D | 1 |
| Cleveland, ZI | 1 |
| Zhou, YM | 1 |
| Akinyi, TG | 1 |
| Dunn, RS | 1 |
| Davidson, CR | 1 |
| Guo, J | 2 |
| Woods, JC | 1 |
| Pereira, RM | 1 |
| dos Santos, RA | 1 |
| Oliveira, EA | 1 |
| Leite, VH | 1 |
| Dias, FL | 1 |
| Rezende, AS | 1 |
| Costa, LP | 1 |
| Barcelos, LS | 1 |
| Teixeira, MM | 1 |
| Simoes e Silva, AC | 1 |
| Kim, MY | 1 |
| Baik, SK | 1 |
| Park, DH | 1 |
| Jang, YO | 1 |
| Suk, KT | 1 |
| Yea, CJ | 1 |
| Lee, IY | 1 |
| Kim, JW | 1 |
| Kim, HS | 1 |
| Kwon, SO | 1 |
| Cho, MY | 1 |
| Ko, SB | 1 |
| Chang, SJ | 1 |
| Um, SH | 1 |
| Han, KH | 1 |
| Gao, S | 1 |
| Long, CL | 1 |
| Wang, RH | 1 |
| Wang, H | 1 |
| Schlueter, N | 1 |
| Hardt, M | 1 |
| Klimek, J | 1 |
| Ganss, C | 1 |
| Abdelhalim, MA | 1 |
| Siddiqi, NJ | 1 |
| Alhomida, AS | 1 |
| Al-Ayed, MS | 1 |
| Beloborodova, EV | 1 |
| Beloborodova, EI | 1 |
| Akbasheva, OE | 1 |
| Serebrov, VIu | 1 |
| Chernogoriuk, GE | 1 |
| Rachkovskiĭ, MI | 1 |
| Purlik, IL | 1 |
| Ostanko, VL | 1 |
| Chvyrina, DV | 1 |
| Shimbori, C | 2 |
| Shiota, N | 2 |
| Okunishi, H | 2 |
| Putiatina, AN | 1 |
| Knight, V | 1 |
| Tchongue, J | 1 |
| Lourensz, D | 1 |
| Tipping, P | 1 |
| Sievert, W | 1 |
| Konstantinidis, I | 1 |
| Papageorgiou, SN | 1 |
| Kyrgidis, A | 1 |
| Tzellos, TG | 1 |
| Kouvelas, D | 1 |
| Appenroth, D | 1 |
| Beutinger, R | 1 |
| Lupp, A | 1 |
| Fleck, C | 1 |
| Erickson, R | 1 |
| Trouard, T | 1 |
| Galons, JP | 1 |
| Gillies, R | 1 |
| Kondou, H | 1 |
| Mushiake, S | 1 |
| Etani, Y | 1 |
| Miyoshi, Y | 1 |
| Michigami, T | 1 |
| Ozono, K | 1 |
| Tanaka, H | 1 |
| Komai, M | 1 |
| Nagao, K | 1 |
| Ishizaki, M | 1 |
| Kajiwara, D | 1 |
| Takatsu, K | 1 |
| Delespesse, G | 1 |
| Nagai, H | 1 |
| Laws, N | 1 |
| Hoey, A | 1 |
| Braun, JT | 1 |
| Ogilvie, JW | 1 |
| Akyuz, E | 1 |
| Brodke, DS | 1 |
| Bachus, KN | 1 |
| Chai, S | 1 |
| Chai, Q | 1 |
| Danielsen, CC | 1 |
| Hjorth, P | 1 |
| Nyengaard, JR | 1 |
| Ledet, T | 1 |
| Yamaguchi, Y | 1 |
| Rasmussen, LM | 1 |
| Wogensen, L | 1 |
| Lee, HS | 1 |
| Shun, CT | 1 |
| Chiou, LL | 1 |
| Chen, CH | 1 |
| Huang, GT | 1 |
| Sheu, JC | 1 |
| Zhao, HF | 1 |
| Ito, T | 1 |
| Gibo, J | 1 |
| Kawabe, K | 1 |
| Oono, T | 1 |
| Kaku, T | 1 |
| Arita, Y | 1 |
| Zhao, QW | 1 |
| Usui, M | 1 |
| Egashira, K | 1 |
| Nawata, H | 1 |
| Mora, AL | 1 |
| Torres-González, E | 1 |
| Rojas, M | 1 |
| Xu, J | 1 |
| Ritzenthaler, J | 1 |
| Speck, SH | 1 |
| Roman, J | 1 |
| Brigham, K | 1 |
| Stecenko, A | 1 |
| Mizushige, T | 1 |
| Mizushige, K | 1 |
| Miyatake, A | 1 |
| Kishida, T | 1 |
| Ebihara, K | 1 |
| Tanabe, J | 1 |
| Izawa, A | 1 |
| Takemi, N | 1 |
| Miyauchi, Y | 1 |
| Torii, Y | 1 |
| Tsuchiyama, H | 1 |
| Suzuki, T | 1 |
| Sone, S | 1 |
| Ando, K | 1 |
| Nakaya, I | 1 |
| Wada, T | 1 |
| Furuichi, K | 1 |
| Sakai, N | 1 |
| Kitagawa, K | 1 |
| Yokoyama, H | 1 |
| Ishida, Y | 1 |
| Kondo, T | 1 |
| Sugaya, T | 1 |
| Kawachi, H | 1 |
| Shimizu, F | 1 |
| Narumi, S | 1 |
| Haino, M | 1 |
| Gerard, C | 1 |
| Matsushima, K | 1 |
| Kaneko, S | 1 |
| Qiu, JF | 1 |
| Zhang, ZQ | 1 |
| Chen, W | 1 |
| Wu, ZY | 1 |
| Ask, K | 1 |
| Labiris, R | 1 |
| Farkas, L | 1 |
| Moeller, A | 1 |
| Froese, A | 1 |
| Farncombe, T | 1 |
| McClelland, GB | 1 |
| Inman, M | 1 |
| Gauldie, J | 1 |
| Kolb, MR | 1 |
| Knorr, A | 1 |
| Hirth-Dietrich, C | 1 |
| Alonso-Alija, C | 1 |
| Härter, M | 1 |
| Hahn, M | 1 |
| Keim, Y | 1 |
| Wunder, F | 1 |
| Stasch, JP | 1 |
| Jimenez, PA | 1 |
| Glasson, SS | 1 |
| Trubetskoy, OV | 1 |
| Haimes, HB | 1 |
| Klinger, JR | 1 |
| Warburton, RR | 1 |
| Pietras, L | 1 |
| Oliver, P | 1 |
| Fox, J | 1 |
| Smithies, O | 1 |
| Hill, NS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry (SESI-MS) in Patients With Pulmonary Fibrosis[NCT02437448] | 31 participants (Actual) | Observational | 2015-06-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for hydroxyproline and Disease Exacerbation
| Article | Year |
|---|---|
Effect of non-steroidal anti-inflammatory drugs on bone turnover: an evidence-based review.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Bone and Bones; Bone Density; Bone Remodeling; | 2013 |
38 other studies available for hydroxyproline and Disease Exacerbation
| Article | Year |
|---|---|
Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH).
Topics: Actins; Animals; Choline Deficiency; Collagen; Diet, High-Fat; Disease Progression; Early Diagnosis; | 2019 |
Correlations between Extracellular Matrix Components in Mouse Lungs during Chronic BCG-Induced Granulomatosis.
Topics: Animals; BCG Vaccine; Disease Progression; Extracellular Matrix; Galactose; Glycosaminoglycans; Gran | 2018 |
Molecular breath analysis supports altered amino acid metabolism in idiopathic pulmonary fibrosis.
Topics: Aged; Alanine; Amino Acids; Area Under Curve; Biomarkers; Breath Tests; Case-Control Studies; Diseas | 2019 |
Long-acting human serum albumin-thioredoxin fusion protein suppresses bleomycin-induced pulmonary fibrosis progression.
Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Blotting, Western; Bronchoalveolar Lavage Fluid; Di | 2013 |
Bone marrow-derived stromal cells are invasive and hyperproliferative and alter transforming growth factor-α-induced pulmonary fibrosis.
Topics: Adoptive Transfer; Animals; Bone Marrow Cells; Bone Marrow Transplantation; Cell Movement; Cell Prol | 2014 |
Modulation of thioacetamide-induced liver fibrosis/cirrhosis by sildenafil treatment.
Topics: Animals; Collagen; Disease Progression; Hydroxyproline; Liver; Liver Cirrhosis; Liver Cirrhosis, Exp | 2013 |
Whey-hydrolyzed peptide-enriched immunomodulating diet prevents progression of liver cirrhosis in rats.
Topics: Animals; Antioxidants; Cattle; Dimethylnitrosamine; Disease Progression; Glutathione; Hyaluronic Aci | 2014 |
Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung.
Topics: Actins; Administration, Inhalation; Animals; Anti-Inflammatory Agents; Bleomycin; Collagen; Connecti | 2016 |
Optimized Mouse Models for Liver Fibrosis.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; | 2017 |
Magnetic resonance imaging of disease progression and resolution in a transgenic mouse model of pulmonary fibrosis.
Topics: Animals; Disease Models, Animal; Disease Progression; Hydroxyproline; Imaging, Three-Dimensional; Ma | 2017 |
Development of hepatorenal syndrome in bile duct ligated rats.
Topics: Animals; Bile Ducts; Creatinine; Disease Models, Animal; Disease Progression; Hepatorenal Syndrome; | 2008 |
Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting En | 2008 |
K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Topics: Animals; Aorta, Abdominal; Atrial Natriuretic Factor; Blood Pressure; Cardiovascular Agents; Disease | 2009 |
Influence of the digestive enzymes trypsin and pepsin in vitro on the progression of erosion in dentine.
Topics: Analysis of Variance; Collagen; Dentin; Disease Progression; Humans; Hydroxyproline; In Vitro Techni | 2010 |
The changes in various hydroxyproline fractions in aortic tissue of rabbits are closely related to the progression of atherosclerosis.
Topics: Animals; Aorta; Atherosclerosis; Cholesterol; Cholesterol, LDL; Collagen; Dietary Fats; Disease Mode | 2010 |
[The parameters of collagen proteolytic and metabolic systems in chronic liver diseases of viral and toxic etiologies].
Topics: alpha 1-Antitrypsin; Biomarkers; Biopsy; Chemical and Drug Induced Liver Injury, Chronic; Collagen; | 2010 |
Involvement of leukotrienes in the pathogenesis of silica-induced pulmonary fibrosis in mice.
Topics: Acute Disease; Animals; Bronchoalveolar Lavage Fluid; Cysteine; Disease Models, Animal; Disease Prog | 2010 |
[Dynamics of biochemical markers of reparative fibrosis in uncomplicated course of myocardial infarction].
Topics: Adult; Aged; Biomarkers; Disease Progression; Echocardiography; Electrocardiography; Female; Fibrone | 2010 |
Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells.
Topics: Animals; Carbon Tetrachloride; Cell Proliferation; Cells, Cultured; Collagen; Cytokines; Disease Mod | 2012 |
Pranlukast, a cysteinyl leukotriene type 1 receptor antagonist, attenuates the progression but not the onset of silica-induced pulmonary fibrosis in mice.
Topics: Animals; Bronchoalveolar Lavage Fluid; Chromones; Cytokines; Disease Progression; Female; Hydroxypro | 2012 |
Effects of a therapy with losartan and quinaprilat on the progression of chronic renal failure in rats after a single dose of uranyl nitrate or 5/6 nephrectomy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Disease | 2003 |
Magnetization transfer contrast imaging in Niemann pick type C mouse liver.
Topics: Animals; Cholesterol; Collagen; Disease Progression; Hydroxyproline; Liver; Magnetic Resonance Imagi | 2003 |
A blocking peptide for transforming growth factor-beta1 activation prevents hepatic fibrosis in vivo.
Topics: Animals; Atrophy; Dimethylnitrosamine; Disease Progression; DNA-Binding Proteins; Hydroxyproline; Li | 2003 |
Role of interleukin-5 and eosinophils in allergen-induced airway remodeling in mice.
Topics: Actins; Allergens; Animals; Antibodies; Asthma; Bronchi; Chemotaxis, Leukocyte; Collagen; Disease Mo | 2004 |
Progression of kyphosis in mdx mice.
Topics: Aging; Animals; Disease Progression; Fibrosis; Hydroxyproline; Kyphosis; Mice; Mice, Inbred mdx; Mus | 2004 |
Fusionless scoliosis correction using a shape memory alloy staple in the anterior thoracic spine of the immature goat.
Topics: Alloys; Animals; Cold Temperature; Disease Progression; Electrocoagulation; Equipment Design; Female | 2004 |
Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis.
Topics: Actins; Animals; Aorta; Apolipoproteins E; Arteriosclerosis; Biomechanical Phenomena; Diabetic Angio | 2005 |
Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: Emphasis on sampling variability.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Biomarkers; Biopsy, Needle; Child; | 2005 |
Anti-monocyte chemoattractant protein 1 gene therapy attenuates experimental chronic pancreatitis induced by dibutyltin dichloride in rats.
Topics: Actins; Animals; Blotting, Western; Chemokine CCL2; Chemokines; Cytokines; Disease Models, Animal; D | 2005 |
Control of virus reactivation arrests pulmonary herpesvirus-induced fibrosis in IFN-gamma receptor-deficient mice.
Topics: Animals; Antigens, Viral; Arginase; beta-N-Acetylhexosaminidases; Biomarkers; Bronchoalveolar Lavage | 2007 |
Inhibitory effects of soy isoflavones on cardiovascular collagen accumulation in rats.
Topics: Analysis of Variance; Animals; Aorta, Thoracic; Blood Glucose; Blood Pressure; Cardiovascular System | 2007 |
Interferon-beta reduces the mouse liver fibrosis induced by repeated administration of concanavalin A via the direct and indirect effects.
Topics: Animals; Collagen; Collagen Type I; Concanavalin A; Cytokines; Disease Progression; Drug Evaluation, | 2007 |
Blockade of IP-10/CXCR3 promotes progressive renal fibrosis.
Topics: Animals; Antibodies, Monoclonal; Cells, Cultured; Chemokine CXCL10; Chemokines, CXC; Disease Progres | 2007 |
Cystamine ameliorates liver fibrosis induced by carbon tetrachloride via inhibition of tissue transglutaminase.
Topics: Actins; Animals; Carbon Tetrachloride; Collagen; Cystamine; Disease Progression; Enzyme Inhibitors; | 2007 |
Comparison between conventional and "clinical" assessment of experimental lung fibrosis.
Topics: Adenoviridae; Animals; Collagen; Disease Models, Animal; Disease Progression; Female; Gene Transfer | 2008 |
Nitric oxide-independent activation of soluble guanylate cyclase by BAY 60-2770 in experimental liver fibrosis.
Topics: Animals; Benzoates; Biphenyl Compounds; Blood Pressure; Carbon Tetrachloride Poisoning; Chemical and | 2008 |
Spontaneous osteoarthritis in Dunkin Hartley guinea pigs: histologic, radiologic, and biochemical changes.
Topics: Animals; Cartilage, Articular; Cell Division; Collagen; Disease Progression; Femur; Guinea Pigs; Hyd | 1997 |
Targeted disruption of the gene for natriuretic peptide receptor-A worsens hypoxia-induced cardiac hypertrophy.
Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Carotid Arteries; Disease Progression; Guanylate C | 2002 |